GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kabra Drugs Ltd (BOM:524322) » Definitions » Cyclically Adjusted PB Ratio

Kabra Drugs (BOM:524322) Cyclically Adjusted PB Ratio : (As of Jun. 04, 2025)


View and export this data going back to 1993. Start your Free Trial

What is Kabra Drugs Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Kabra Drugs Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Kabra Drugs's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kabra Drugs Cyclically Adjusted PB Ratio Chart

Kabra Drugs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.84 1.07 1.83 2.97

Kabra Drugs Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.97 - 3.60 -

Competitive Comparison of Kabra Drugs's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Kabra Drugs's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kabra Drugs's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kabra Drugs's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Kabra Drugs's Cyclically Adjusted PB Ratio falls into.


;
;

Kabra Drugs Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Kabra Drugs's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Kabra Drugs's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book=Book Value per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0/158.3229*158.3229
=0.000

Current CPI (Dec. 2024) = 158.3229.

Kabra Drugs Quarterly Data

Book Value per Share CPI Adj_Book
201503 5.935 97.163 9.671
201506 0.000 99.841 0.000
201509 5.991 101.753 9.322
201512 0.000 102.901 0.000
201603 5.521 102.518 8.526
201606 0.000 105.961 0.000
201609 6.123 105.961 9.149
201612 0.000 105.196 0.000
201703 5.817 105.196 8.755
201706 0.000 107.109 0.000
201709 4.453 109.021 6.467
201712 0.000 109.404 0.000
201803 0.448 109.786 0.646
201806 0.000 111.317 0.000
201809 0.445 115.142 0.612
201812 0.000 115.142 0.000
201903 0.073 118.202 0.098
201906 0.000 120.880 0.000
201909 -0.036 123.175 -0.046
201912 0.000 126.235 0.000
202003 -0.063 124.705 -0.080
202006 0.000 127.000 0.000
202009 -0.156 130.118 -0.190
202012 0.000 130.889 0.000
202103 -0.473 131.771 -0.568
202106 0.000 134.084 0.000
202109 -0.678 135.847 -0.790
202112 0.000 138.161 0.000
202203 -0.896 138.822 -1.022
202206 0.000 142.347 0.000
202209 -1.203 144.661 -1.317
202212 0.000 145.763 0.000
202303 -1.666 146.865 -1.796
202306 0.000 150.280 0.000
202309 -2.249 151.492 -2.350
202312 0.000 152.924 0.000
202403 2.467 153.035 2.552
202406 0.000 155.789 0.000
202409 3.255 157.882 3.264
202412 0.000 158.323 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kabra Drugs  (BOM:524322) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Kabra Drugs Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Kabra Drugs's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kabra Drugs Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Swaminathan Street, 2nd Floor, West Mambalam, Chennai, TN, IND, 600 033
Kabra Drugs Ltd is an India-based drug manufacturing company. It is engaged in the business of Permaculture manufacturing and trading in pharma related products. Geographically, all the company operations are carried out in India. The company's drug manufacturing plant is located in Madhya Pradesh, India. Its products include Cardiovascular Drugs, Anti-Infective Drugs, Oncology Drugs, Gastroenterologic Drugs, Hormonal Drugs, etc.

Kabra Drugs Headlines

No Headlines